Alexion Pharmaceuticals - 22 Year Stock Price History | ALXN

Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Alexion Pharmaceuticals as of November 14, 2018 is 116.11.
Alexion Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 121.0570 124.0500 139.0100 106.0400 116.1100 -2.91%
2017 125.7262 122.6300 146.6900 97.7000 119.5900 -2.26%
2016 134.8574 184.6800 184.9000 110.0100 122.3500 -35.86%
2015 177.6471 186.6000 207.8400 145.6000 190.7500 3.09%
2014 166.7312 133.4400 200.7900 129.8200 185.0300 39.24%
2013 104.9874 100.0500 132.9100 83.3900 132.8840 41.76%
2012 94.2987 70.5700 118.1500 70.2900 93.7400 31.10%
2011 53.8780 40.6650 71.5500 40.6650 71.5000 77.53%
2010 29.1347 24.1250 41.1700 22.7500 40.2750 64.99%
2009 20.1819 18.0650 24.4100 15.8250 24.4100 34.90%
2008 18.1343 18.8775 23.7525 12.7425 18.0950 -3.53%
2007 13.6236 10.1525 19.9500 8.9425 18.7575 85.76%
2006 8.7138 5.0725 11.3500 5.0150 10.0975 99.46%
2005 6.0305 6.0925 7.4975 4.6550 5.0625 -19.64%
2004 4.9553 4.3125 6.3750 3.3925 6.3000 48.15%
2003 3.8358 3.6250 5.2300 2.5850 4.2525 20.47%
2002 4.0792 5.7750 6.5650 2.3950 3.5300 -42.23%
2001 6.3246 15.3900 18.6875 3.7375 6.1100 -62.37%
2000 17.8134 7.3750 29.0750 6.9375 16.2350 115.53%
1999 3.2124 3.1250 7.8450 2.1095 7.5325 125.19%
1998 2.7282 2.9700 3.7500 1.5000 3.3450 7.04%
1997 2.7061 2.1875 3.8450 2.0313 3.1250 43.84%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $26.441B $3.551B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.059B 13.80
Gilead Sciences (GILD) United States $91.744B 11.05
Biogen (BIIB) United States $64.289B 13.02
Celgene (CELG) United States $49.115B 9.53
Illumina (ILMN) United States $45.743B 53.28
Vertex Pharmaceuticals (VRTX) United States $43.524B 76.03
Regeneron Pharmaceuticals (REGN) United States $36.966B 18.75
BioMarin Pharmaceutical (BMRN) United States $16.652B 0.00
Incyte (INCY) United States $13.562B 374.88
Seattle Genetics (SGEN) United States $8.782B 0.00
Exact Sciences (EXAS) United States $8.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.959B 25.45
Sarepta Therapeutics (SRPT) United States $7.803B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.800B 0.00
Bluebird Bio (BLUE) United States $6.579B 0.00
BeiGene (BGNE) Cayman Islands $6.166B 0.00
Bio-Techne Corp (TECH) United States $6.117B 41.32
Galapagos (GLPG) Belgium $5.266B 0.00
Alkermes (ALKS) Ireland $5.263B 3387.00
Exelixis (EXEL) United States $4.978B 14.11
Amarin (AMRN) Ireland $4.496B 0.00
Horizon Pharma Public (HZNP) Ireland $3.663B 15.07
Immunomedics (IMMU) United States $3.576B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.569B 0.00
Emergent Biosolutions (EBS) United States $3.400B 28.64
Allogene Therapeutics (ALLO) United States $3.192B 0.00
Ligand Pharmaceuticals (LGND) United States $3.155B 24.14
Guardant Health (GH) United States $3.148B 0.00
Array BioPharma (ARRY) United States $3.134B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.987B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.974B 0.00
Repligen (RGEN) United States $2.868B 89.57
Genomic Health (GHDX) United States $2.814B 95.00
Blueprint Medicines (BPMC) United States $2.642B 0.00
Ascendis Pharma (ASND) Denmark $2.564B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.471B 0.00
China Biologic Products (CBPO) China $2.418B 17.22
Allakos (ALLK) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Akcea Therapeutics (AKCA) United States $2.333B 0.00
MyoKardia (MYOK) United States $2.279B 0.00
REGENXBIO (RGNX) United States $2.247B 30.14
Myriad Genetics (MYGN) United States $2.242B 22.22
Halozyme Therapeutics (HALO) United States $2.238B 49.94
ACADIA Pharmaceuticals (ACAD) United States $2.228B 0.00
Amicus Therapeutics (FOLD) United States $2.041B 0.00
Global Blood Therapeutics (GBT) United States $1.973B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.893B 0.00
AnaptysBio (ANAB) United States $1.870B 0.00
Reata Pharmaceuticals (RETA) United States $1.823B 0.00
Medicines (MDCO) United States $1.684B 0.00
Aimmune Therapeutics (AIMT) United States $1.666B 0.00
Arena Pharmaceuticals (ARNA) United States $1.662B 0.00
Denali Therapeutics (DNLI) United States $1.640B 0.00
Innoviva (INVA) United States $1.636B 9.25
G1 THERAPEUTICS (GTHX) United States $1.618B 0.00
Spark Therapeutics (ONCE) United States $1.611B 0.00
Atara Biotherapeutics (ATRA) United States $1.587B 0.00
Cambrex (CBM) United States $1.580B 11.80
NeoGenomics (NEO) United States $1.535B 126.92
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.532B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.481B 0.00
Rubius Therapeutics (RUBY) United States $1.390B 0.00
Editas Medicine (EDIT) United States $1.386B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.356B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Myovant Sciences (MYOV) United Kingdom $1.277B 0.00
Insmed (INSM) United States $1.233B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.223B 0.00
Mirati Therapeutics (MRTX) United States $1.210B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.184B 94.04
WAVE Life Sciences (WVE) Singapore $1.151B 0.00
Solid Biosciences (SLDB) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.103B 0.00
Cellectis (CLLS) France $1.071B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.004B 0.00
Audentes Therapeutics (BOLD) United States $1.003B 0.00
Retrophin (RTRX) United States $0.999B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.979B 0.00
Intra-Cellular Therapies (ITCI) United States $0.947B 0.00
DBV Technologies (DBVT) France $0.943B 0.00
Acorda Therapeutics (ACOR) United States $0.918B 11.63
Alder BioPharmaceuticals (ALDR) United States $0.901B 0.00
UniQure (QURE) Netherlands $0.892B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.891B 0.00
Lion Biotechnologies (IOVA) United States $0.877B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.860B 0.00
Apellis Pharmaceuticals (APLS) United States $0.856B 0.00
Aptinyx (APTX) United States $0.854B 0.00
Fate Therapeutics (FATE) United States $0.844B 0.00
Puma Biotechnology (PBYI) United States $0.841B 0.00
Viking Therapeutics (VKTX) United States $0.824B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.815B 0.00
Clovis Oncology (CLVS) United States $0.804B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.804B 0.00
Revance Therapeutics (RVNC) United States $0.803B 0.00
Intellia Therapeutics (NTLA) United States $0.793B 0.00
Athenex (ATNX) United States $0.779B 0.00
Coherus BioSciences (CHRS) United States $0.758B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Heska (HSKA) United States $0.742B 60.72
Dynavax Technologies (DVAX) United States $0.739B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.723B 0.00
InflaRx (IFRX) Germany $0.720B 0.00
AVROBIO (AVRO) United States $0.717B 0.00
Vericel (VCEL) United States $0.713B 0.00
TWIST BIOSCIENC (TWST) United States $0.649B 0.00
Novavax (NVAX) United States $0.647B 0.00
UROGEN PHARMA (URGN) Israel $0.646B 0.00
CytomX Therapeutics (CTMX) United States $0.642B 0.00
ANI Pharmaceuticals (ANIP) United States $0.612B 11.73
Gritstone Oncology (GRTS) United States $0.601B 0.00
Epizyme (EPZM) United States $0.600B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.588B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.587B 0.00
Principia Biopharma (PRNB) United States $0.575B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.567B 0.00
Senesco Technologies (ELOX) United States $0.561B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.560B 0.00
Scholar Rock Holding (SRRK) United States $0.556B 0.00
Arvinas (ARVN) United States $0.549B 0.00
UNITY Biotechnology (UBX) $0.531B 0.00
ObsEva SA (OBSV) Switzerland $0.514B 0.00
Eidos Therapeutics (EIDX) United States $0.510B 0.00
Anika Therapeutics (ANIK) United States $0.509B 21.07
Arcus Biosciences (RCUS) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.478B 0.00
BeyondSpring (BYSI) United States $0.464B 0.00
Inovio Pharmaceuticals (INO) United States $0.461B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.460B 0.00
Prothena (PRTA) Ireland $0.456B 0.00
Kura Oncology (KURA) United States $0.441B 0.00
Sorrento Therapeutics (SRNE) United States $0.435B 71.20
Replimune (REPL) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.429B 0.00
MediciNova (MNOV) United States $0.426B 0.00
Kindred Biosciences (KIN) United States $0.424B 0.00
PDL BioPharma (PDLI) United States $0.422B 6.88
Zymeworks (ZYME) Canada $0.417B 0.00
Five Prime Therapeutics (FPRX) United States $0.399B 0.00
RA PHARMCTL INC (RARX) United States $0.397B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.374B 0.00
Zealand Pharma (ZEAL) Denmark $0.374B 0.00
Verastem (VSTM) United States $0.373B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
Osiris Therapeutics (OSIR) United States $0.369B 0.00
Abeona Therapeutics (ABEO) United States $0.368B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.366B 0.00
Cytokineticsorporated (CYTK) United States $0.356B 0.00
MeiraGTx Holdings (MGTX) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
ResTORbio (TORC) United States $0.310B 0.00
LogicBio Therapeutics (LOGC) United States $0.305B 0.00
Sutro Biopharma (STRO) United States $0.304B 0.00
Liquidia Technologies (LQDA) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
Kodiak Sciences (KOD) United States $0.298B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.297B 0.00
Krystal Biotech (KRYS) United States $0.295B 0.00
Geron (GERN) United States $0.291B 0.00
MannKind (MNKD) United States $0.290B 0.00
Kadmon Holdings (KDMN) United States $0.287B 0.00
Celcuity (CELC) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.265B 0.00
Athersys (ATHX) United States $0.265B 0.00
Arbutus Biopharma (ABUS) Canada $0.265B 0.00
Syros Pharmaceuticals (SYRS) United States $0.262B 0.00
Equillium (EQ) United States $0.260B 0.00
BioDelivery Sciences (BDSI) United States $0.256B 0.00
Aduro Biotech (ADRO) United States $0.254B 0.00
Evelo Biosciences (EVLO) United States $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Agenus (AGEN) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.234B 0.00
Unum Therapeutics (UMRX) United States $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.233B 0.00
Proteostasis Therapeutics (PTI) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Magenta Therapeutics (MGTA) United States $0.228B 0.00
Urovant Sciences (UROV) United States $0.222B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
BioTime (BTX) United States $0.221B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Kamada (KMDA) Israel $0.219B 20.15
Corvus Pharmaceuticals (CRVS) United States $0.212B 0.00
Idera Pharmaceuticals (IDRA) United States $0.207B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.205B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.194B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
NantKwest (NK) United States $0.188B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.172B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.165B 20.30
Compugen (CGEN) Israel $0.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
Cerecor (CERC) United States $0.157B 0.00
Cohbar (CWBR) United States $0.156B 0.00
Menlo Therapeutics (MNLO) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Pfenex (PFNX) United States $0.153B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
PSivida (EYPT) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.140B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Eleven Biotherapeutics (SESN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.129B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Cue Biopharma (CUE) United States $0.122B 0.00
Mustang Bio (MBIO) United States $0.120B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
XOMA (XOMA) United States $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Provention Bio (PRVB) United States $0.102B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Chiasma (CHMA) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Monster Digital (INNT) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Cel-Sci (CVM) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ITUS (ANIX) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.058B 9.38
Oncobiologics (ONS) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Trevena (TRVN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
OncoSec Medical (ONCS) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.042B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AEterna Zentaris (AEZS) United States $0.039B 7.44
Versartis (ARAV) United States $0.039B 6.29
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.035B 0.00
GTx (GTXI) United States $0.035B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.61
Vical (VICL) United States $0.028B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00